Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
VISEN Pharmaceuticals ( (HK:2561) ) just unveiled an update.
VISEN Pharmaceuticals has announced its Annual General Meeting scheduled for June 27, 2025, in Shanghai, China. Key agenda items include the re-election of several directors, reappointment of Ernst & Young as auditors, and granting directors the authority to repurchase shares and issue additional shares. These resolutions aim to enhance corporate governance and provide flexibility in capital management, potentially impacting the company’s operational strategies and shareholder value.
More about VISEN Pharmaceuticals
VISEN Pharmaceuticals is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company focuses on developing and providing pharmaceutical products and services, with a market presence indicated by its listing on the Hong Kong Stock Exchange.
YTD Price Performance: -36.34%
Average Trading Volume: 341,572
For an in-depth examination of 2561 stock, go to TipRanks’ Stock Analysis page.